Qilu (Osimertinib) 80mg*30 | Qilu China Generic | GLT

Generic Information: Qilu Osimertinib 80mg — China-Mainland

This listing is the osimertinib generic manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd., a subsidiary of Qilu Pharmaceutical, one of China's largest pharmaceutical groups. Supplied as 80 mg film-coated tablets in a 30-tablet pack, the product matches the originator's standard strength. Qilu's osimertinib generic has passed China's generic-drug quality and efficacy consistency evaluation and is available through China's national reimbursement channels, making it a regulatory-assured, lower-cost option.

Qilu Pharmaceutical is headquartered in Shandong with manufacturing sites across China, including Hainan, where this product is produced. For buyers, the Qilu generic offers a Chinese-made osimertinib whose bioequivalence to the originator has been formally reviewed.

What Is Qilu Osimertinib Used For?

Qilu osimertinib treats EGFR mutation-positive non-small cell lung cancer, including first-line advanced disease, T790M-positive disease after resistance to a prior EGFR TKI, and adjuvant therapy after surgery in eligible EGFR-mutant patients. Its blood-brain barrier penetration supports use when central nervous system metastases are present.

How Does Qilu Osimertinib Work?

Osimertinib is an irreversible mutant-selective EGFR tyrosine kinase inhibitor. It blocks EGFR bearing exon 19 deletions, L858R mutations and the T790M mutation while sparing wild-type EGFR, which explains its multi-line efficacy and its relatively manageable rash and diarrhoea.

Indications

• First-line advanced EGFR-mutant NSCLC.
• Adjuvant therapy after resection of EGFR-mutant NSCLC.
• T790M-positive NSCLC after prior EGFR-TKI therapy.

Dosage and Administration

The dose is 80 mg once daily, with or without food, swallowed whole. Missed doses beyond 12 hours are skipped. A 40 mg daily dose may be used for side-effect management, and treatment continues until progression or unacceptable toxicity.

Side Effects

Common side effects include diarrhoea, rash, dry skin, nail changes, stomatitis and fatigue. Rare but serious events such as interstitial lung disease, QT prolongation and cardiomyopathy require monitoring; new respiratory symptoms or palpitations should be reported promptly.

Storage

Store below 30°C, in the original package, in a dry place, away from children. Use before the expiry date.

Why Choose the China Version of Qilu Osimertinib?

The Qilu generic benefits from China's competitive pricing and national reimbursement, making it one of the most affordable regulatory-approved ways to access osimertinib — typically a small fraction of the branded originator's Western list price. Because the product has passed bioequivalence review, patients gain a quality-assured, lower-cost option. GLT documents each batch and guides buyers through import and export requirements.

How to Order Qilu Osimertinib from GLT

Contact GLT on WhatsApp at +86 15234153837 or email [email protected] to order Qilu osimertinib 80 mg (30 tablets). Provide your quantity, destination and order type, and we will confirm availability, batch details and export documentation before dispatch.

FAQ

Who makes Qilu osimertinib? Qilu osimertinib is manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd., part of the Qilu Pharmaceutical group in China.

Is Qilu osimertinib a generic of Tagrisso? Yes, it contains the same active ingredient (osimertinib) at the same 80 mg dose as Tagrisso.

Can I buy Qilu osimertinib online? Yes, GLT can supply it internationally; contact us on WhatsApp or email for availability.